Combined Blockade of Lipid Uptake and Synthesis by CD36 Inhibitor and SCD1 siRNA Is Beneficial for the Treatment of Refractory Prostate Cancer.

导出 LinkOut

翻译打印收藏纠错

作者： Jiyuan,Chen ^[1] ; Xiaoyan,Yu ^[1] ; Gang,Yang ^[1] ; Xueying,Chen ^[2] ; Chunai,Gong ^[1] ; Lu,Han ^[1] ; Yujie,Wang ^[1] ; Rong,Wang ^[1] ; Lei,Wang ^[1] ; Yongfang,Yuan ^[1]

作者单位： Department of Pharmacy, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, P. R. China. ^[1] Department of Stomatology, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510655, P. R. China. ^[2]

关键词 CD36 SCD1 drug resistance lipid metabolism refractory prostate cancer

DOI 10.1002/advs.202412244

PMID 39736148

发布时间 2024-12-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

e2412244页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Combined Blockade of Lipid Uptake and Synthesis by CD36 Inhibitor and SCD1 siRNA Is Beneficial for the Treatment of Refractory Prostate Cancer.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

相似文献

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Combined Blockade of Lipid Uptake and Synthesis by CD36 Inhibitor and SCD1 siRNA Is Beneficial for the Treatment of Refractory Prostate Cancer.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

相似文献

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

相关期刊

检索历史清除